NEC
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

NEC Trademark

Serial Number: 79394301 • Registration: 7665783

NEC is a trademark filed by Nippon Denki Kabushiki Kaisha (NEC Corporation) on November 8, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Nippon Denki Kabushiki Kaisha (NEC Corporation) (59 trademarks)

7-1, Shiba 5-chome,

Entity Type: 03

Trademark Details

Filing Date

November 8, 2023

Registration Date

January 28, 2025

Published for Opposition

December 10, 2024

Goods & Services

Downloadable and recorded computer software for use in analyzing and identifying genome information; Downloadable and recorded computer software for medical process management of individual personalized treatment; Downloadable and recorded computer software for patient stratification; Downloadable and recorded operating system computer software for use with companion diagnostic medical devices; Downloadable and recorded computer software platforms for use in medical data management; Downloadable and recorded computer operating programs; Downloadable and recorded computer operating system software; computers and computer hardware; computer network servers; computer peripheral apparatus; Downloadable and recorded computer software and downloadable application software for collecting and storage of patient data and medical information; Data processing equipment in the nature of data processing systems for collecting and storage of patient data and medical information

Vaccines; vaccines preparations; vaccine preparations for the prevention and treatment of cancer, infection and auto immune disease; pharmaceuticals and pharmaceutical preparations for human use for the prevention and treatment of cancer, infection and auto immune disease; companion diagnostic agents for medical use; pharmaceutical preparations for the treatment and prevention of cancer, infection and auto immune disease namely cellular therapeutics; pharmaceutical preparations for the treatment of cell related viral diseases; reagent paper for medical purposes; dietary supplements for humans; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; dietetic beverages adapted for medical purposes, namely, drinks for babies; food for babies; dietary supplements for animals

Collection of information into computer databases in the field of genetic and genomic information and life science; Collection of genome information into computer databases for medical purposes; collection of information into computer databases in the field of medical information

Providing medical information related to the preservation of genome information for medical purposes; Providing medical information in the nature of collected genome information; providing medical information in the field of cellular therapeutics; medical diagnostic testing and monitoring services in the field of cellular therapeutics, namely, cell therapy; medical assistance services in the nature of information about genetic testing and medical information provided to remote medical professionals via the Internet and global computer networks through the use of genome sequence information, medical images, diagnostic test results, and data storage and retrieval systems; medical services relating to the collection, processing and preservation of biological samples; collection and preservation of biological samples, namely, human cells; medical laboratory services for the analysis of biological samples; medical analysis services for diagnostic and treatment provided by medical laboratories relating to cell, tissue, gene expression, gene sequence, genome annotation, transcriptome characteristic analysis, genome mapping; provision of medical information; physical examination services; providing an internet website for medical professionals and medical patients featuring medical information and medical data which users process, exchange and access in real time

Research and development of vaccines and medicines; scientific research in the nature of conducting clinical trials for others; research and development of medicines in the nature of companion diagnostic agent; testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs; scientific research in the field of genetics; medical research; design and development of computer hardware and software for use in companion diagnostic; designing of machines, apparatus, instruments and their parts or systems composed of such machines, apparatus and instruments; technology advisory and consultancy services relating to the design and development of computer hardware; computer programming; medical and scientific research in the field of gene analysis; Scientific and technological services, namely, genome research, testing, analysis, and evaluation of genome samples for scientific research purposes and providing information thereof; Scientific and technological services, namely, investigation and analysis of genome samples for scientific research purposes; providing on-line non downloadable software for use in analyzing and identifying genome information; providing on-line non downloadable software for medical process management of individual personalized treatment; providing on-line non downloadable software for patient stratification; providing on-line non downloadable operating system software for use with companion diagnostic medical devices; platform as a service (PaaS) featuring computer software platforms for use in medical data management; design and development of computer software for medical data analysis and management; rental of computers; providing temporary use of on-line non- downloadable cloud computing software and computer programs on data networks for medical data management; software as a service (SaaS) featuring software for medical data management; research and development in the field of cellular therapeutics; structural and functional analysis of genomes; Providing information about medical research, namely, genome information analysis; Scientific and technological services, namely, providing scientific analysis in the field of genomic data; providing on-line non downloadable software for use in collecting, analyzing, evaluating, interpreting and predicting genetic and genomic information; providing science information in the fields of genetic and genomic information and life science; Biological research in the nature of analysis of biological samples

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Oct 10, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 24, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Sep 24, 2025 OPNR
FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 5, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Aug 16, 2025 FICS
FINAL DISPOSITION PROCESSED
Aug 16, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 29, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 28, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 28, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 10, 2024 NPUB
PUBLISHED FOR OPPOSITION
Dec 10, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 4, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 14, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 8, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 8, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 8, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 8, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 16, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 16, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 16, 2024 TROA
REFUSAL PROCESSED BY IB
Aug 11, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 23, 2024 RFCS
REFUSAL PROCESSED BY MPU
Jul 23, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 27, 2024 RFCR
NON-FINAL ACTION WRITTEN
Jun 26, 2024 CNRT
ASSIGNED TO EXAMINER
Jun 17, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
May 10, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 10, 2024 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
May 2, 2024 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 25, 2024 REPR